In contrast to the previous report where myeloid-specific deletion of Sirt2 failed to display long-lasting changes in TB control (Cardoso et al., 2015), administration of AGK2 significantly diminished the bacterial growth at early time points as well as at chronic late phase of infection. This evidence concerns the gene SIRT2 and tuberculosis.